Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160,621 | 165,489 | 166,485 | 181,270 | 184,282 |
| Receivables | 11,050 | 4,861 | 17,920 | 18,329 | 24,192 |
| Inventories | 13,099 | 12,824 | 10,854 | 11,096 | 9,800 |
| TOTAL | $188,372 | $186,949 | $200,716 | $215,881 | $221,431 |
| Non-Current Assets | |||||
| PPE Net | 10,176 | 8,561 | 7,314 | 7,095 | 6,378 |
| Intangibles | 2,553 | 2,555 | 2,558 | 2,570 | 2,526 |
| Other Non-Current Assets | 9,399 | 8,541 | 8,494 | 9,706 | 8,631 |
| TOTAL | $22,128 | $19,657 | $18,366 | $19,371 | $17,535 |
| Total Assets | $210,500 | $206,606 | $219,082 | $235,252 | $238,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,371 | 1,658 | 4,461 | 2,420 | 3,085 |
| Accrued Expenses | 7,916 | 8,089 | 8,490 | 10,396 | 8,718 |
| Other current liabilities | N/A | N/A | N/A | N/A | 4,218 |
| TOTAL | $11,801 | $10,812 | $14,032 | $13,819 | $16,728 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 32 | N/A | 30 |
| Deferred Revenues | 27 | 34 | 43 | 19 | 174 |
| Other Non-Current Liabilities | 7,440 | 6,901 | 7,010 | 7,742 | 7,239 |
| TOTAL | $7,440 | $6,901 | $7,042 | $7,742 | $7,269 |
| Total Liabilities | $19,241 | $17,713 | $21,074 | $21,561 | $23,997 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,962 | 25,956 | 25,946 | 26,205 | 26,447 |
| Common Shares | 272 | 272 | 272 | 276 | 278 |
| Retained earnings | -101,484 | -101,335 | -91,650 | -84,033 | -81,485 |
| Other shareholders' equity | -8,876 | -10,275 | -10,188 | -7,461 | -10,425 |
| TOTAL | $191,259 | $188,893 | $198,008 | $213,691 | $214,969 |
| Total Liabilities And Equity | $210,500 | $206,606 | $219,082 | $235,252 | $238,966 |